Stock Information

Revance Therapeutics Inc (RVNC)

Revance Therapeutics Inc logo
Ticker Symbol: RVNC
Exchange: NASDAQ
Sector: N/A
Market Cap: $382,605,158.00 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.9453
Revenue (TTM): $2.37 M
Dividend Yield: N/A%
ROE: -482.92%

Latest News

Key Financials

Financial data not available